Delic Holdings Appoints Dr. Eric Janusson As Lead Chemist
Complex Biotech Discovery Ventures Ltd., a licensed cannabis and psilocybin research laboratory, has appointed Dr. Eric Janusson as its lead chemist.
The news was released Wednesday by psychedelic wellness-focused company
Delic Holdings Inc. (CSE:DELC) (OTCQB:DELCF), which plans to acquire the laboratory.
Janusson, who specializes in real-time methods for the quantification and characterization of sensitive chemical intermediates, earned his Ph.D. in analytical chemistry at the University of Victoria in 2017.
Dr. Markus Roggen, Director of Delic Corp & Founder of CBDV, said he was excited to have Janusson on board. [Janusson] is instrumental to combine our analytical platforms with our machine learning capabilities, Roggen added.